Correlation Between ICON PLC and Verve Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both ICON PLC and Verve Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ICON PLC and Verve Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ICON PLC and Verve Therapeutics, you can compare the effects of market volatilities on ICON PLC and Verve Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ICON PLC with a short position of Verve Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ICON PLC and Verve Therapeutics.

Diversification Opportunities for ICON PLC and Verve Therapeutics

-0.1
  Correlation Coefficient

Good diversification

The 3 months correlation between ICON and Verve is -0.1. Overlapping area represents the amount of risk that can be diversified away by holding ICON PLC and Verve Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verve Therapeutics and ICON PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ICON PLC are associated (or correlated) with Verve Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verve Therapeutics has no effect on the direction of ICON PLC i.e., ICON PLC and Verve Therapeutics go up and down completely randomly.

Pair Corralation between ICON PLC and Verve Therapeutics

Given the investment horizon of 90 days ICON PLC is expected to under-perform the Verve Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, ICON PLC is 2.08 times less risky than Verve Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The Verve Therapeutics is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest  599.00  in Verve Therapeutics on August 30, 2024 and sell it today you would lose (21.00) from holding Verve Therapeutics or give up 3.51% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

ICON PLC  vs.  Verve Therapeutics

 Performance 
       Timeline  
ICON PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ICON PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with abnormal performance in the last few months, the Stock's essential indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.
Verve Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Verve Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

ICON PLC and Verve Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with ICON PLC and Verve Therapeutics

The main advantage of trading using opposite ICON PLC and Verve Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ICON PLC position performs unexpectedly, Verve Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verve Therapeutics will offset losses from the drop in Verve Therapeutics' long position.
The idea behind ICON PLC and Verve Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.

Other Complementary Tools

Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years